The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.
Like all things in life including life itself, the world s largest industry meeting in aging research came to a close. Here is a report on Day 5 of the meeting.
Day four out of five of the 10th ARDD was full of new revelations. For example we learned that that median lifespan of taurine-treated mice increased by 10 to 12%!